Hesperidin methylchalcone是一种来源于柑橘的化合物,具有强效的抗氧化和抗炎活性。它通过抑制氧化应激、细胞因子产生和 NF-κB 活化来减少炎症和疼痛,同时具有血管保护作用。Hesperidin methylchalcone 在心血管疾病、炎症性疾病和抗氧化保健品领域中具有潜在应用价值。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Hesperidin methylchalcone, an orally active flavonoid, possesses analgesic, anti-inflammatory, and antioxidant effects. It demonstrates vasoprotective activity and inhibits oxidative stress, cytokine production, and NF-κB activation. Hesperidin methylchalcone is applicable in gout disease research[1][2]. |
| 体内研究 | Hesperidin methylchalcone (0.03-3 mg/kg, i.p., once time) dose-dependently reduces the increase of renal dysfunction markers (urea and creatinine) caused by SDCF in mice[1]. Hesperidin methylchalcone (3 mg/kg, i.p., once time) effectively mitigates oxidative stress induced by SDCF in the renal tissue of mice[1]. Hesperidin methylchalcone (3 mg/kg, i.p., single dose) alleviates SDCF-induced renal histopathology, swelling, and cytotoxicity in tubular cells of mice[1]. Hesperidin methylchalcone (3-30 mg/kg, p.o., single dose) dose-dependently diminishes MSU-induced hyperalgesia, edema, and leukocyte infiltration in mice[2]. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | TiO2-induced chronic arthritis model | Intraperitoneal injection | 100 mg/kg | Once daily for 30 days | HMC inhibited mechanical hyperalgesia, thermal hyperalgesia, joint edema, leukocyte recruitment, and oxidative stress in the knee joint (alterations in gp91phox, GSH, superoxide anion, and lipid peroxidation) and in recruited leukocytes (total reactive oxygen species and GSH); reduced patellar proteoglycan degradation; and decreased pro-inflammatory cytokine production. HMC also reduced the activation of nociceptor-sensory TRPV1+ and TRPA1+ neurons. These effects occurred without renal, hepatic, or gastric damage. | Molecules. 2023 Jan 15;28(2):872 |
| Swiss mice | Diclofenac-induced acute kidney injury | Intra-peritoneal injection | 0.03–3 mg/kg | Single dose, evaluated after 24 hours | To evaluate the protective effects of HMC on diclofenac-induced acute kidney injury. Results showed that HMC dose-dependently improved renal function markers (urea and creatinine levels), reduced oxidative stress and inflammatory responses. | Antioxidants (Basel). 2022 Jun 27;11(7):1261 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.60mL 0.32mL 0.16mL |
8.01mL 1.60mL 0.80mL |
16.01mL 3.20mL 1.60mL |
|
| CAS号 | 24292-52-2 |
| 分子式 | C29H36O15 |
| 分子量 | 624.59 |
| SMILES Code | OC1=CC(O[C@@H]([C@H](O)[C@H]2O)O[C@@H]([C@H]2O)CO[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)=CC(OC)=C1C(/C=C/C4=CC(O)=C(OC)C=C4)=O |
| MDL No. | MFCD00010438 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | FDHNLHLOJLLXDH-JIYHLSBYSA-N |
| Pubchem ID | 6436550 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(80.05 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1